Keywords: astra, expected, first, quarter, turnover, swedish, pharmaceutical
Astra As Expected In First Quarter
Article | 20 May 1996
Turnover at Swedish pharmaceutical group Astra in the first quarter of 1996 was ahead 8% to 9.3 billion Swedish kroner ($1.3 billion). Pretax profits ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
